Product Reports Resources Pricing Login Book a demo

Infermedica

Health Tech & Medtech · Wroclaw, Poland · Founded 2012

A leading digital health company specialized in AI-powered solutions for preliminary diagnosis and patient triage MoreLess

Infermedica, established in Poland in 2012, operates as a health-tech company focused on improving primary care access and efficiency. The founding story traces back to CEO Piotr Orzechowski's background as a game developer. Inspired by an AI-powered 20-questions game, he questioned if the same adaptive learning process could be applied to medical symptom checking, moving beyond the static decision trees common at the time. This idea formed the company's foundation. Orzechowski, an IT entrepreneur with experience in several startups, co-founded the company with Irving Loh, MD, and Roberto Sicconi, PhD, whom he met in Silicon Valley.

The firm provides a B2B Medical Guidance Platform for healthcare organizations, including insurers like Allianz and Cigna, providers, and telemedicine companies. Revenue is generated by offering its technology as white-label, API-first solutions that integrate into clients' existing systems, such as patient portals and mobile apps. This business model is designed to help clients reduce costs, increase efficiency, and improve patient flow by guiding individuals to the appropriate level of care. As of January 2022, Infermedica has raised a total of $45 million over several funding rounds, including a $30 million Series B round led by One Peak. These funds are earmarked for further development of the platform and global expansion.

Infermedica's core technology is an AI engine built upon a vast medical knowledge base, developed with over 140,000 hours of physician input. The platform consists of several modules that cover the primary care journey. The "Triage" module is a sophisticated symptom checker that uses a dynamic, AI-driven interview to analyze a user's condition and suggest the right level of care, from self-care to an emergency room visit. The "Intake" module automates patient information gathering before a consultation, aiming to streamline appointment workflows and reduce administrative work for clinicians. A "Follow-Up" module is also in development. The system's AI leverages natural language processing to make medical information more understandable to patients and has achieved a 95% accuracy rate for its engine. The platform is utilized in over 30 countries and is available in more than 20 languages.

Keywords: medical guidance platform, patient triage, symptom checker, AI in healthcare, digital health, patient intake automation, clinical decision support, health-tech, medical diagnostics AI, virtual triage, healthcare API, primary care automation, medical chatbot, healthcare cost reduction, patient navigation, B2B health tech, telehealth solutions, insurance tech, medical knowledge base, AI-powered diagnosis

Valuation $100–500M
Revenue $1–10M
Headcount 100–500
Total funding $10–50M
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Infermedica and the history behind them.

Company overview

Infermedica company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2012
Headquarters
Wroclaw, Poland
Employees
170
Open positions
None listed
Dealroom signal
64.6
client focusb2btechnologyArtificial IntelligencetechnologyDeep Techsub industryHealth Platformbusiness modelSaaSindustryHealthsectorRisk ManagementsectorPredictive AnalyticssectorTelemedicinesectorCore AIsectorHealth DiagnosticssectorVirtual AssistantsectorTech for Hospitals and ClinicssectorClinical Decision Support

Valuation & funding

Infermedica funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BEquity / VC Jan 2022 $30M $120M Karma Ventures · Heal capital · European Bank for Reconstruction and Development · PharmStars Ventures
SERIES AEquity / VC Aug 2020 $9.7M $39M Karma Ventures · European Bank for Reconstruction and Development · Dreamit Ventures · Inovo.vc
SEEDEquity / VC Jun 2019 $3.7M $15M Dreamit Ventures · Innovation Nest · RTA Capital · Karma Ventures
SEEDEquity / VC Jan 2019 $1.1M $4.2M Undisclosed
GRANTOther financing Dec 2016 $55K European Innovation Council
SEEDEquity / VC Jun 2016 RTAventures
SEEDEquity / VC Jan 2016 Venture Inc.
SEEDEquity / VC Nov 2013 Innovation Nest
SUPPORT PROGRAMOther financing Dec 2012 Google for Startups Accelerator
SUPPORT PROGRAMOther financing Jun 2012 PORT Polish Center for Technology Development
Showing 10 recorded eventsUnlock the complete deal history →

Financials

Revenue, earnings and profit over time

Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.

YearRevenueGrowthEBITDAMarginProfitMarginR&D
2026 $3.1M 0% −$1.3M -39.9% −$2.5M -81.2% $1.1M
2025 $3.1M 0% −$1.3M -39.9% −$2.5M -81.2% $1.1M
2024 $3.1M 0% −$1.3M -39.9% −$2.5M -81.2% $1.1M
2023 $3.1M 0% −$1.3M -39.9% $1.1M
2022 $3.1M 0% −$1.3M -39.9%
2021 $3.1M +97.4% −$1.3M -39.9%
2020 $1.6M −$376K -23.6%
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Infermedica website traffic

Latest recorded traffic for Infermedica is 23K monthly website visits, up 27.8% over the last three months. Infermedica's team declined 11.5% over the past year.

Latest monthly visits23K 3-month web change+27.8% 1-year team growth-11.5%
Monthly website visits125 observations · Feb 2016–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Hiring

Open positions at Infermedica

Current openings linked to this company in Dealroom.

1 distinct opening shownExplore hiring signals →

Comparisons

Infermedica compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Infermedica's talent

Book a demo to see the people
Team profiled 16 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

20 investors on Infermedica's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 9 investors entered at this stage
Innovation Nest
Venture Inc.
RTAventures
European Innovation Council
Karma Ventures
Dreamit Ventures
RTA Capital
Inovo.vc
Müller Medien
Series A 4 investors entered at this stage
European Bank for Reconstruction and Development
Heal capital
One Peak Partners
PharmStars Ventures
Other known 7 additional known investors
Google for Startups Accelerator
PORT Polish Center for Technology Development
Dr. Christian Weiss
EBRD Venture Capital
PFR Ventures
Plug and Play
Unfold.vc

Global footprint

Where Infermedica has talent and traffic

Workforce by country
13 countries with
team presence
🇵🇱 Poland74.5%
🇺🇸 United States7.5%
🇮🇹 Italy2.1%
🇩🇪 Germany2.1%
🇨🇦 Canada2.1%
Top 5 of 13 shown

In the news

Latest news about Infermedica

Recent press, funding announcements, and product moves mentioning Infermedica — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Infermedica

An AI-synthesized read of the highest-engagement posts about Infermedica on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Infermedica’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.